Lineage Cell Therapeutics, Inc.Lineage Cell Therapeutics, Inc.Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc.

No trades
See on Supercharts

LCTX fundamentals

The current financial position of Lineage Cell Therapeutics, Inc.

Total assets of LCTX for Q1 24 is 108.48 M USD, 7.39% more than the previous Q4 23. And total liabilities decreased by 3.85% in Q1 24 to 37.49 M USD.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Total assets
Total liabilities
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Total assetsYoY growth
Total equityYoY growth